Business Context and Reporting Period
This Form 8-K filing by Aptiv PLC, dated March 5, 2026, reports on the finalization of the previously announced separation (Spin-Off) of Versigent Limited. The filing details the distribution of Versigent shares to Aptiv shareholders and the upcoming independent trading of the new entity.
Key Financial Metrics
The filing text does not provide specific values for revenue, profit, cash flow, margins, debt, or liquidity. The document focuses exclusively on the structural details of the corporate separation rather than reporting period financial performance.
Material Changes
- Corporate Structure: Aptiv will distribute all ordinary shares of Versigent Limited to Aptiv shareholders as a pro rata dividend.
- Trading Status: Versigent shares are expected to begin trading on the New York Stock Exchange under the ticker "VGNT" on April 1, 2026.
- Entity Conversion: Prior to the Spin-Off, Versigent Limited is expected to convert into a Jersey public limited company and be renamed Versigent PLC.
Guidance, Outlook, and Risks
Distribution Terms: Holders of Aptiv ordinary shares will receive one ordinary share of Versigent for every three ordinary shares of Aptiv held on the record date of March 17, 2026. The distribution is subject to the satisfaction or waiver of certain conditions.
Risks and Uncertainties: The filing includes standard forward-looking statement disclaimers. Key risks cited include the success of executing the Spin-Off, satisfaction of pre-conditions, macroeconomic volatility, geopolitical conflicts, supply chain disruptions, and the impact of interest rates and commodity prices. The company also notes risks related to its de-leveraging and capital allocation plans.
Investor Verification Checklist
- Verify the record date of March 17, 2026, to confirm eligibility for the Versigent share distribution.
- Confirm the 1:3 distribution ratio (one Versigent share for every three Aptiv shares).
- Monitor the status of conditions precedent required to complete the Spin-Off.
- Check for the commencement of Versigent trading under ticker "VGNT" on April 1, 2026.
- Review the attached Press Release (Exhibit 99.1) for additional details on the separation.